Internal Medicine, Rheumatology · Winfield, IL
NPI
1891801510
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
25 N Winfield Rd, Ste 400
Winfield, IL, 60190
Phone (630) 268-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$528K
103,795 services
Medicare patients, 2024
270
Average age 73
Drug cost, 2024
$2.6M
2,359 prescriptions
Company payments, 2025
$208
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elisa Y Rhew was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 92,006 times for 26 patients. In total Elisa Y Rhew billed 103,795 services in 71 codes, and Medicare paid $528K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 92,006 | 26 | $3.60 | $332K |
| J0897 Injection, denosumab, 1 mg | Office | 2,340 | 23 | $20.49 | $48K |
| 36415 Venipuncture Blood Collection | Office | 604 | 208 | $8.65 | $5,225 |
| 99214 Office E&M - Established | Office | 599 | 238 | $93.52 | $56K |
| 85025 Blood Count | Office | 539 | 195 | $7.60 | $4,096 |
| 86140 Clinical Chemistry | Office | 534 | 195 | $5.07 | $2,709 |
| 85652 Clinical Chemistry | Office | 531 | 195 | $2.65 | $1,405 |
| 80076 Clinical Chemistry | Office | 516 | 188 | $8.00 | $4,127 |
| 82565 Clinical Chemistry | Office | 490 | 194 | $5.01 | $2,453 |
| 84520 Clinical Chemistry | Office | 477 | 190 | $3.86 | $1,843 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 394 | 203 | $12.79 | $5,038 |
| 96372 Injection Administration | Office | 248 | 53 | $11.06 | $2,743 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 185 | 43 | $0.79 | $146 |
| 99213 Office E&M - Established | Office | 140 | 48 | $68.24 | $9,554 |
| 86160 Immunoassay | Office | 123 | 35 | $11.76 | $1,446 |
By year: 2022 $618K for 109,893 services; 2023 $530K for 101,269 services; 2024 $528K for 103,795 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 604 | 208 | $8.65 | $5,225 |
| 85025 Blood Count | 539 | 195 | $7.60 | $4,096 |
| 86140 Clinical Chemistry | 534 | 195 | $5.07 | $2,709 |
| 85652 Clinical Chemistry | 531 | 195 | $2.65 | $1,405 |
| 80076 Clinical Chemistry | 516 | 188 | $8.00 | $4,127 |
| 82565 Clinical Chemistry | 490 | 194 | $5.01 | $2,453 |
| 84520 Clinical Chemistry | 477 | 190 | $3.86 | $1,843 |
| 86160 Immunoassay | 123 | 35 | $11.76 | $1,446 |
| 82306 Clinical Chemistry | 96 | 74 | $29.01 | $2,785 |
| 84156 Clinical Chemistry | 55 | 32 | $3.60 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Elisa Y Rhew prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 471 prescriptions and refills. In total Elisa Y Rhew wrote 2,359 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 471 | 1,356 | 150 | $18K |
| Methotrexate Methotrexate Sodium | 446 | 1,218 | 142 | $15K |
| Prednisone Generic | 282 | 797 | 100 | $2,462 |
| Leflunomide Generic | 103 | 308 | 33 | $7,554 |
| Allopurinol Generic | 102 | 291 | 26 | $1,136 |
| Xeljanz Xr Tofacitinib Citrate | 83 | 103 | 11 | $615K |
| Methylprednisolone Generic | 76 | 82 | 52 | $589 |
| Sulfasalazine Generic | 59 | 171 | 19 | $2,028 |
| Sulfasalazine Dr Sulfasalazine | 55 | 164 | 20 | $3,726 |
| Folic Acid Generic | 53 | 160 | 17 | $877 |
| Celecoxib Generic | 47 | 126 | 19 | $2,853 |
| Enbrel Sureclick Etanercept | 44 | 66 | 11 | $504K |
| Alendronate Sodium Generic | 42 | 118 | 18 | $463 |
| Orencia Abatacept | 37 | 66 | Under 11 | $389K |
| Colchicine Generic | 36 | 100 | 14 | $2,896 |
Brand drugs: - claims; generic drugs: 1,974 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elisa Y Rhew $208 ($208 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $63.16.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.